Stage at Diagnosis and Surgical Management of Breast Cancer at Dumai Regional Hospital, 2020–2025
Abstract
Breast cancer remains the most frequently diagnosed malignancy among women and a major contributor to cancer-related morbidity, while late-stage presentation continues to constrain surgical options in many regional referral settings. This study aimed to describe the stage at diagnosis and patterns of surgical management, and to examine the association between clinical stage and type of surgery among breast cancer patients treated at Dumai Regional Hospital, Riau, Indonesia. A retrospective hospital-based study was conducted using medical records from January 2020 to October 2025, with total sampling of eligible cases (n = 137). Variables included age, clinical stage at diagnosis based on the AJCC 8th edition (grouped as stage I–II and stage III–IV), and surgical procedure (conservative surgery, modified radical mastectomy, or biopsy/non-definitive procedures). Descriptive statistics were used to summarise patient characteristics and management patterns. The association between clinical stage and type of surgery was tested using the chi-square test, and effect size was estimated using Cramer’s V. Most patients were aged 40–59 years (58.4%), with a mean age of 52.5 years (SD 11.5), and the majority presented at advanced stages (stage III–IV: 62.8%). Modified radical mastectomy was the predominant procedure (64.2%), while conservative surgery accounted for a smaller proportion. Clinical stage was significantly associated with the type of surgery performed (chi-square = 12.3; df = 2; p < 0.001; Cramer’s V = 0.30). These findings indicate a persistent predominance of late-stage presentation in this regional hospital, underscoring the need to strengthen early detection pathways and timely referral to expand eligibility for breast-conserving management.
Keywords
Full Text:
PDFReferences
Global cancer statistics 2020: “GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries”. CA: A Cancer Journal for Clinicians, Vol 71, no 3, p. e 209-249. [Online]. Available: https://doi.org/10.3322/caac.21660
H. Sung, J. Ferlay, R. L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, and F. Bray, “Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries,” CA: A Cancer Journal for Clinicians, vol. 71, no. 3, pp. 209–249, 2021. [Online]. Available: https://doi.org/10.3322/caac.21660
World Health Organization, “Global Breast Cancer Initiative,” 2023. [Online]. Available: https://www.who.int/initiatives/global-breast-cancer-initiative
Ministry of Health of the Republic of Indonesia, “Cancer Prevention and Control Framework (National Cancer Control Programme),” 2022. [Online]. Available: https://kemkes.go.id/eng/layanan/cancer-prevention-and-control-framework
Gradishar, W. J., et al (2022). Breast cancer, version 2.2022, NCCN Clinical Practice Guidelines in Oncology.Journal of the National Comprehensive Cancer Network, Vol 20, no 6, p. e691-722.
[Online]. Available: https://doi.org/10.6004/jnccn.2022.0030
Youlden, D. R., Baade, P. D., Walker, R., & Pyke, C. (2020).
The role of hospital-based cancer registries in cancer control: A systematic review.
Asia-Pacific Journal of Clinical Oncology, Vol 16, no 2, p. e61-70.
[Online]. Available: https://doi.org/10.1111/ajco.13239
H. M. Peacock, L. van Walle, G. Silversmit, et al., Breast cancer incidence, stage distribution, and treatment shifts during the 2020 COVID‐19 pandemic: a nationwide population-level study, Arch. Public Health, vol. 82, p. 66, May 2024. [Online]. Available: https://link.springer.com/article/10.1186/s13690-024-01296-3
Z. Bi, W. H. Cheng, W. H. Zheng, et al., The optimal timing of breast cancer surgery after COVID-19 infection: an observational study, BMC Cancer, vol. 24, p. 1348, Nov. 2024. [Online]. Available: https://link.springer.com/article/10.1186/s12885-024-13080-1?
K. Van Baelen, J. Van Cauwenberge, M. Maetens, et al., Reporting on invasive lobular breast cancer in clinical trials: a systematic review, npj Breast Cancer, vol. 10, p. 23, Mar. 2024. [Online]. Available: https://www.nature.com/articles/s41523-024-00627-5?
Y. Liu, Recent advances and updated highlights in breast cancer pathologic diagnosis: a narrative review, Transl. Breast Cancer Res., 2025. [Online]. Available: https://tbcr.amegroups.org/article/view/95796/
H. M. Peacock, et al., Breast cancer incidence, stage distribution, and treatment shifts during the 2020 COVID-19 pandemic, Arch. Public Health, 82:66, 2024. [Online]. Available: https://link.springer.com/article/10.1186/s13690-024-01296-3?
J. C. Broglio et al., Survival outcomes of breast-conserving surgery versus mastectomy after neoadjuvant therapy, Cancers, vol. 17, p. 766, 2024. [Online]. Available: https://www.mdpi.com/2072-6694/17/5/766
Breast-Conserving Surgery vs Mastectomy for Non-metastatic Breast Cancer: Systematic Review and Meta-analysis, Cureus, 2025. [Online]. Available: https://www.cureus.com/articles/378832-breast-conserving-surgery-vs-mastectomy-for-non-metastatic-breast-cancer-a-systematic-review-and-meta-analysis-of-observational-studies?#!/
Breast cancer highlights from 2023: Knowledge to guide practice and future research, Breast, 2024. [Online]. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC10869942/?
C. Helal, L. Djerroudi, T. Ramtohul, et al., Clinico-pathological factors predicting pathological response in early TNBC, npj Breast Cancer, 2025. [Online]. Available: https://www.nature.com/articles/s41523-025-00729-8?
Comparative review of global breast cancer screening guidelines, Dove Press, 2025. [Online]. Available: https://www.dovepress.com/beyond-the-age-limit-a-comparative-study-70-vs-70-years-in-breast-canc-peer-reviewed-fulltext-article-BCTT
DOI: https://doi.org/10.37311/ijpe.v6i1.36638
Refbacks
- There are currently no refbacks.
Copyright (c) 2026 Delidios Arimbi, Ami Amelia

Indonesian Journal of Pharmaceutical Education is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.


